A Registered Cohort Study on Wilson's Disease

Status Recruiting

Clinical Trial Summary

The aim of this study is to determine the clinical spectrum and natural progression of Wilson's Disease in a prospective multicenter natural history study, to assess the clinical, genetic, epigenetic features and biomarkers of patients with Wilson's Disease to optimize clinical management.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Wilson's Disease

Clinical Trial Details

NCT number	NCT04012658
Study type	Observational
Source	First Affiliated Hospital of Fujian Medical University
Contact	Jin He, MD
Phone	86-0591-87982772
Email	hejinfjmu@hotmail.com
Status	Recruiting
Phase
Start date	July 1, 2019
Completion date	December 2049

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04537377` - A Phase I/II Study of VTX-801 in Adult Patients With Wilson's Disease	Phase 1/Phase 2
Not yet recruiting	`NCT06051734` - Early Detection of Cardiac Affection in Patients of Wilson's Disease
Active, not recruiting	`NCT02252380` - ExAblate Transcranial MRgFUS for the Management of Treatment-Refractory Movement Disorders	N/A
Completed	`NCT01874028` - A Phase 1 Study to Assess the Effects in the Body of a Single Dose of Trientine Dihydrochloride in Wilson's Disease Patients	Phase 1
Recruiting	`NCT05183165` - Description of the Copper Concentration in Breast Milk in Women Treated for Wilson's Disease	N/A
Completed	`NCT00212355` - Efficacy and Safety, Long-term Study of Zinc Acetate to Treat Wilson's Disease in Japan.	Phase 3
Recruiting	`NCT05493605` - Cardiac Involvement in Wilson's Disease	N/A
Recruiting	`NCT03957720` - The Individual Therapy for Patients With Wilson's Disease	Early Phase 1
Recruiting	`NCT05239858` - International Wilson's Disease Patient Registry (iWilson Registry)
Completed	`NCT02552628` - WILSTIM - DBS (WILson STIMulation - Deep Brain Stimulation)	N/A
Completed	`NCT06128954` - Study Comparing Once Daily Dose of 900mg of TETA 4HCL Against Cuprior® (450mg Trientine Base, Twice Daily).	Phase 1
Recruiting	`NCT05305872` - Gandouling in the Treatment of Wilson's Disease	Phase 4
Recruiting	`NCT04212195` - Cohort Research on Wilson's Disease
Completed	`NCT01378182` - Efficacy of Invitro Expanded Bone Marrow Derived Allogeneic Mesenchymal Stem Cell Transplantation Via Portal Vein or Hepatic Artery or Peripheral Vein in Patients With Wilson Cirrhosis	N/A